Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
indocyanine green (ic-green) (1 trial)
pegsitacianine (2 trials)
cemiplimab (libtayo) (1 trial)
onm-501 (1 trial)
Carcinoma (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Trials (4 total)
Trial APIs (4 total)